Iodide

Iodide

SCHEMBL5158487

[I-].c1ccc([P+](CC2OCCO2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.43
TSHR P16473 2/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
SNCA P37840 2/20 0.35
TDP1 Q9NUW8 1/20 0.31
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL510812 0.96 HIF1A (0.43) HIF1ATSHRALDH1A1CYP1A2CYP2D6
Bromide SCHEMBL4637900 0.89 HIF1A (0.40) HIF1ATSHRALDH1A1CYP1A2CYP2D6
Iodide SCHEMBL8876694 0.78 HIF1A (0.47) HIF1ATSHRALDH1A1CYP1A2CYP2D6
Water SCHEMBL8528246 0.77 HIF1A (0.50) HIF1ATSHRALDH1A1CYP1A2CYP2D6
Bromide SCHEMBL1454426 0.77 HIF1A (0.50) HIF1ATSHRALDH1A1CYP1A2CYP2D6
Hydrochloric Acid SCHEMBL28584063 0.73 HIF1A (0.44) HIF1ATSHRALDH1A1CYP1A2CYP2D6
Iodide SCHEMBL2414352 0.73 HIF1A (0.40) HIF1ATSHRALDH1A1CYP1A2CYP2D6
Bromide SCHEMBL9822359 0.73 ALDH1A1 (0.39) HIF1ATSHRALDH1A1SNCATDP1
Iodide SCHEMBL13280558 0.72 HIF1A (0.48) HIF1ATSHRALDH1A1CYP1A2CYP2D6
Hydrochloric Acid SCHEMBL8583704 0.71 HIF1A (0.47) HIF1ATSHRALDH1A1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1262476-B1 PROCESSES FOR PREPARING QUINOLINE DERIVATIVES AND INTERMEDIATES THEREOF NISSAN CHEMICAL IND LTD (JP) 2007-01-10 EP disclosed
US-6855824-B2 Processes for preparing quinoline derivatives and intermediates thereof KURARAY CO., LTD. (JP) 2005-02-15 US disclosed
US-20030125355-A1 Processes for preparing quinoline derivatives and intermedias thereof NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2003-07-03 US disclosed
EP-1262476-A1 PROCESSES FOR PREPARING QUINOLINE DERIVATIVES AND INTERMEDIATES THEREOF KURARAY CO., LTD. (JP) 2002-12-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030125355-A1 Processes for preparing quinoline derivatives and intermedias thereof NQO1, ADH1B, IDH3B HIF1A 3040/4885TSHR 4101/4885ALDH1A1 79/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.